161 related articles for article (PubMed ID: 15818619)
1. Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
Wakisaka N; Yoshizaki T; Raab-Traub N; Pagano JS
Int J Cancer; 2005 Sep; 116(4):640-5. PubMed ID: 15818619
[TBL] [Abstract][Full Text] [Related]
2. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
3. Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
Murono S; Raab-Traub N; Pagano JS
Cancer Res; 2001 Nov; 61(21):7875-7. PubMed ID: 11691806
[TBL] [Abstract][Full Text] [Related]
4. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
Neyts J; Sadler R; De Clercq E; Raab-Traub N; Pagano JS
Cancer Res; 1998 Feb; 58(3):384-8. PubMed ID: 9458076
[TBL] [Abstract][Full Text] [Related]
5. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
6. Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir.
Yoshizaki T; Wakisaka N; Kondo S; Murono S; Shimizu Y; Nakashima M; Tsuji A; Furukawa M
J Med Virol; 2008 May; 80(5):879-82. PubMed ID: 18360900
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
[TBL] [Abstract][Full Text] [Related]
8. The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells.
Liekens S; Gijsbers S; Vanstreels E; Daelemans D; De Clercq E; Hatse S
Mol Pharmacol; 2007 Mar; 71(3):695-703. PubMed ID: 17158200
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
[TBL] [Abstract][Full Text] [Related]
10. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
[TBL] [Abstract][Full Text] [Related]
12. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford HL; Munshi NC; Anderson KC
Br J Haematol; 2006 Oct; 135(1):52-61. PubMed ID: 16925573
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice.
De Schutter T; Andrei G; Topalis D; Duraffour S; Mitera T; Naesens L; van den Oord J; Matthys P; Snoeck R
Cancer Lett; 2013 Feb; 329(2):137-45. PubMed ID: 23142293
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
Cook GJ; Caudell DL; Elford HL; Pardee TS
PLoS One; 2014; 9(11):e112619. PubMed ID: 25402485
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime.
Tihan T; Elford HL; Cory JG
Adv Enzyme Regul; 1991; 31():71-83. PubMed ID: 1877400
[TBL] [Abstract][Full Text] [Related]
18. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
Hui KF; Chiang AK
Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
20. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]